4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0000950170-24-137545
Chief R&D Officer acquired 135,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Zalevsky Jonathan · Chief R&D Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-12-13 | Grant or award : show line 1 in the form | +135,000 | 378,019 | D |
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-12-13 | Grant or award : show line 2 in the form Stock Option | +270,000 | 270,000 | D |
| 2024-12-13 | Grant or award : show line 3 in the form Stock Option | +375,000 | 375,000 | D |
Loading xslF345X05/ownership.xml…